Benzinga | Jul 7, 2021 09:40AM EDT

Lixte Biotech Shares Quiet Following Press Release Highlighting Presentation Its Drug Development For Cancer Treatment At TheMoneyShow Virual Expo On Jul. 14, 2021 At 3:20 p.m. EDT

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) ("Lixte" or the "Company"), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, will present at the MoneyShow July Virtual Expo taking place July 13-15, 2021. Registration is free and open to the public.

Event and Registration: MoneyShow July Virtual Expo

Presentation Date: Wednesday, July 14, 2021

Presentation Time: 3:20 p.m. ET

Lixte Founder and CEO John S. Kovach, M.D. will deliver a company overview, featuring the Company's ongoing Phase 1b/2 clinical trial with City of Hope, a world-renowned independent cancer research and treatment center, to assess LB-100 for treatment of extensive stage-disease small cell lung cancer.